# The Effect of Voxelotor on Cerebral Hemodynamic Response in Children With Sickle Cell Anemia

> **NCT05018728** · PHASE2 · TERMINATED · sponsor: **Emory University** · enrollment: 22 (actual)

## Conditions studied

- Sickle Cell Anemia in Children

## Interventions

- **DRUG:** Voxelotor

## Key facts

- **NCT ID:** NCT05018728
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-03-28
- **Primary completion:** 2024-10-22
- **Final completion:** 2024-10-22
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** This study was terminated on September 26, 2024 due to voluntary withdrawal of study drug from the market.
- **Last updated:** 2025-12-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05018728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05018728, "The Effect of Voxelotor on Cerebral Hemodynamic Response in Children With Sickle Cell Anemia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05018728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*